Driehaus Capital Management LLC Ultragenyx Pharmaceutical Inc. Transaction History
Driehaus Capital Management LLC
- $9.27 Billion
- Q2 2024
A detailed history of Driehaus Capital Management LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 528,180 shares of RARE stock, worth $28.3 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
528,180
Previous 528,180
-0.0%
Holding current value
$28.3 Million
Previous $21.7 Million
-0.0%
% of portfolio
0.23%
Previous 0.23%
Shares
5 transactions
Others Institutions Holding RARE
# of Institutions
287Shares Held
88.1MCall Options Held
505KPut Options Held
198K-
Vanguard Group Inc Valley Forge, PA9.78MShares$525 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$301 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.35MShares$287 Million0.68% of portfolio
-
Wellington Management Group LLP Boston, MA4.56MShares$244 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$175 Million2.24% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.76B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...